{
    "2020-01-02": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Nordisk's Shares Up in a Year on Pipeline Progress",
                "features": {
                    "keywords": [
                        "Shares Up",
                        "Pipeline Progress"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward",
                "features": {
                    "keywords": [
                        "Rare Case",
                        "Balanced Risk",
                        "Reward"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novo Nordisk's new insulin affordability offerings now available in the US",
                "features": {
                    "keywords": [
                        "new insulin",
                        "affordability",
                        "US"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}